{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:34:45Z","timestamp":1789450485301,"version":"build-2803163510"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R00AG031293"],"award-info":[{"award-number":["R00AG031293"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG044342"],"award-info":[{"award-number":["R01AG044342"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG062135"],"award-info":[{"award-number":["R01AG062135"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG062135"],"award-info":[{"award-number":["R01AG062135"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS092918"],"award-info":[{"award-number":["R01NS092918"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS086074"],"award-info":[{"award-number":["R01NS086074"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS092093"],"award-info":[{"award-number":["R01NS092093"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS108686"],"award-info":[{"award-number":["R01NS108686"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R21NS084007-01"],"award-info":[{"award-number":["1R21NS084007-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R21NS084007"],"award-info":[{"award-number":["1R21NS084007"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00401-019-02032-w","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T04:42:17Z","timestamp":1559796137000},"page":"551-574","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of \u03b1-synucleinopathy"],"prefix":"10.1007","volume":"138","author":[{"given":"Balvindar","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Covelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Martell-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Nanclares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew A.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Okematti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Meints","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Teravskis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena V.","family":"Savonenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Benneyworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain E.","family":"Lesn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Araque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5865-9682","authenticated-orcid":false,"given":"Michael K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"key":"2032_CR1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1097\/WCO.0b013e3283168df0","volume":"21","author":"D Aarsland","year":"2008","unstructured":"Aarsland D, Beyer MK, Kurz MW (2008) Dementia in Parkinson\u02bcs disease. Curr Opin Neurol 21:676\u2013682. \n                    https:\/\/doi.org\/10.1097\/WCO.0b013e3283168df0","journal-title":"Curr Opin Neurol"},{"key":"2032_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","volume":"13","author":"D Aarsland","year":"2017","unstructured":"Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D et al (2017) Cognitive decline in Parkinson disease. Nat Rev Neurol 13:217\u2013231. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2017.27","journal-title":"Nat Rev Neurol"},{"key":"2032_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","volume":"25","author":"A Abeliovich","year":"2000","unstructured":"Abeliovich A, Schmitz Y, Fari\u00f1as I, Choi-Lundberg D, Ho W-H, Castillo PE et al (2000) Mice lacking \u03b1-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25:239\u2013252. \n                    https:\/\/doi.org\/10.1016\/S0896-6273(00)80886-7","journal-title":"Neuron"},{"key":"2032_CR4","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1523\/JNEUROSCI.3047-16.2016","volume":"37","author":"DH Adamowicz","year":"2017","unstructured":"Adamowicz DH, Roy S, Salmon DP, Galasko DR, Hansen LA, Masliah E et al (2017) Hippocampal \u03b1-synuclein in dementia with Lewy bodies contributes to memory impairment and is consistent with spread of pathology. J Neurosci 37:1675\u20131684. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.3047-16.2016","journal-title":"J Neurosci"},{"key":"2032_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aal2021","author":"F Amar","year":"2017","unstructured":"Amar F, Sherman MA, Rush T, Larson M, Boyle G, Chang L et al (2017) Amyloid-\u03b2 oligomer A\u03b2*56 induces specific alterations of tau phosphorylation and neuronal signaling. Sci Signal. \n                    https:\/\/doi.org\/10.1126\/scisignal.aal2021","journal-title":"Sci Signal"},{"key":"2032_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","volume":"13","author":"M Antunes","year":"2012","unstructured":"Antunes M, Biala G (2012) The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process 13:93\u2013110. \n                    https:\/\/doi.org\/10.1007\/s10339-011-0430-z","journal-title":"Cogn Process"},{"key":"2032_CR7","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/0092-8674(95)90010-1","volume":"81","author":"ME Bach","year":"1995","unstructured":"Bach ME, Hawkins RD, Osman M, Kandel ER, Mayford M (1995) Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal ltp in the range of the \u03b8 frequency. Cell 81:905\u2013915. \n                    https:\/\/doi.org\/10.1016\/0092-8674(95)90010-1","journal-title":"Cell"},{"key":"2032_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1037\/h0077579","volume":"93","author":"CA Barnes","year":"1979","unstructured":"Barnes CA (1979) Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J Comp Physiol Psychol 93:74\u2013104. \n                    https:\/\/doi.org\/10.1037\/h0077579","journal-title":"J Comp Physiol Psychol"},{"key":"2032_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3233\/JAD-170031","volume":"60","author":"AJ Beagle","year":"2017","unstructured":"Beagle AJ, Darwish SM, Ranasinghe KG, La AL, Karageorgiou E, Vossel KA (2017) Relative incidence of seizures and myoclonus in Alzheimer\u2019s Disease, dementia with Lewy bodies, and frontotemporal dementia. J Alzheimers Dis 60:211\u2013223. \n                    https:\/\/doi.org\/10.3233\/JAD-170031","journal-title":"J Alzheimers Dis"},{"key":"2032_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/361031a0","volume":"361","author":"TVP Bliss","year":"1993","unstructured":"Bliss TVP, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31. \n                    https:\/\/doi.org\/10.1038\/361031a0","journal-title":"Nature"},{"key":"2032_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.parkreldis.2016.12.002","volume":"35","author":"A Bougea","year":"2017","unstructured":"Bougea A, Koros C, Stamelou M, Simitsi A, Papagiannakis N, Antonelou R et al (2017) Frontotemporal dementia as the presenting phenotype of p. A53T mutation carriers in the alpha-synuclein gene. Park Relat Disord 35:82\u201387. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2016.12.002","journal-title":"Park Relat Disord"},{"key":"2032_CR12","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1212\/01.wnl.0000312279.49272.9f","volume":"70","author":"H Braak","year":"2008","unstructured":"Braak H, Del Tredici K (2008) Nervous system pathology in sporadic Parkinson disease. Neurology 70:1916\u20131925. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000312279.49272.9f","journal-title":"Neurology"},{"key":"2032_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Tredici KD, R\u00fcb U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211. \n                    https:\/\/doi.org\/10.1016\/S0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"key":"2032_CR14","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burr\u00e9","year":"2010","unstructured":"Burr\u00e9 J, Sharma M, Tsetsenis T, Buchman V, Etherton M, S\u00fcdhof TC (2010) \u03b1-Synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329:1663\u20131667. \n                    https:\/\/doi.org\/10.1126\/science.1195227","journal-title":"Science"},{"key":"2032_CR15","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.1038\/nature12125","volume":"498","author":"J Burr\u00e9","year":"2013","unstructured":"Burr\u00e9 J, Vivona S, Diao J, Sharma M, Brunger AT, S\u00fcdhof TC (2013) Properties of native brain \u03b1-synuclein. Nature 498:E4\u2013E6. \n                    https:\/\/doi.org\/10.1038\/nature12125","journal-title":"Nature"},{"key":"2032_CR16","doi-asserted-by":"publisher","first-page":"E4274","DOI":"10.1073\/pnas.1416598111","volume":"111","author":"J Burr\u00e9","year":"2014","unstructured":"Burr\u00e9 J, Sharma M, S\u00fcdhof TC (2014) \u03b1-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation. Proc Natl Acad Sci 111:E4274\u2013E4283. \n                    https:\/\/doi.org\/10.1073\/pnas.1416598111","journal-title":"Proc Natl Acad Sci"},{"key":"2032_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.biopsych.2017.12.018","volume":"84","author":"DL Castillo-Carranza","year":"2018","unstructured":"Castillo-Carranza DL, Guerrero-Mu\u00f1oz MJ, Sengupta U, Gerson JE, Kayed R (2018) \u03b1-Synuclein oligomers induce a unique toxic tau strain. Biol Psychiatry 84:499\u2013508. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2017.12.018","journal-title":"Biol Psychiatry"},{"key":"2032_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cell.2005.09.028","volume":"123","author":"S Chandra","year":"2005","unstructured":"Chandra S, Gallardo G, Fern\u00e1ndez-Chac\u00f3n R, Schl\u00fcter OM, S\u00fcdhof TC (2005) \u03b1-Synuclein cooperates with CSP\u03b1 in preventing neurodegeneration. Cell 123:383\u2013396. \n                    https:\/\/doi.org\/10.1016\/j.cell.2005.09.028","journal-title":"Cell"},{"key":"2032_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","volume":"9","author":"M-F Chesselet","year":"2012","unstructured":"Chesselet M-F, Richter F, Zhu C, Magen I, Watson MB, Subramaniam SR (2012) A progressive mouse model of Parkinson\u2019s disease: the Thy1-aSyn (\u201cLine 61\u201d) mice. Neurotherapeutics 9:297\u2013314. \n                    https:\/\/doi.org\/10.1007\/s13311-012-0104-2","journal-title":"Neurotherapeutics"},{"key":"2032_CR20","doi-asserted-by":"publisher","first-page":"9694","DOI":"10.1523\/JNEUROSCI.2980-05.2005","volume":"25","author":"J Chin","year":"2005","unstructured":"Chin J, Palop JJ, Puoliv\u00e4li J, Massaro C, Bien-Ly N, Gerstein H et al (2005) Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer\u2019s disease. J Neurosci 25:9694\u20139703. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.2980-05.2005","journal-title":"J Neurosci"},{"key":"2032_CR21","doi-asserted-by":"publisher","first-page":"10427","DOI":"10.1523\/JNEUROSCI.1459-11.2011","volume":"31","author":"M Ciss\u00e9","year":"2011","unstructured":"Ciss\u00e9 M, Sanchez PE, Kim DH, Ho K, Yu G-Q, Mucke L (2011) Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice. J Neurosci 31:10427\u201310431. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1459-11.2011","journal-title":"J Neurosci"},{"key":"2032_CR22","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1523\/JNEUROSCI.5368-11.2012","volume":"32","author":"E Colla","year":"2012","unstructured":"Colla E, Jensen PH, Pletnikova O, Troncoso JC, Glabe C, Lee MK (2012) Accumulation of toxic \u03b1-synuclein oligomer within endoplasmic reticulum occurs in \u03b1-synucleinopathy in vivo. J Neurosci 32:3301\u20133305. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.5368-11.2012","journal-title":"J Neurosci"},{"key":"2032_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/NEN.0000000000000018","volume":"72","author":"M Colom-Cadena","year":"2013","unstructured":"Colom-Cadena M, Gelpi E, Charif S, Belbin O, Blesa R, Mart\u0131 MJ et al (2013) Confluence of \u03b1-synuclein, tau, and \u03b2-amyloid pathologies in dementia with Lewy bodies. J Neuropathol Exp Neurol 72:10","journal-title":"J Neuropathol Exp Neurol"},{"key":"2032_CR24","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1093\/brain\/awx275","volume":"140","author":"M Colom-Cadena","year":"2017","unstructured":"Colom-Cadena M, Pegueroles J, Herrmann AG, Henstridge CM, Mu\u00f1oz L, Querol-Vilaseca M et al (2017) Synaptic phosphorylated \u03b1-synuclein in dementia with Lewy bodies. Brain 140:3204\u20133214. \n                    https:\/\/doi.org\/10.1093\/brain\/awx275","journal-title":"Brain"},{"key":"2032_CR25","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1037\/0735-7044.110.6.1321","volume":"110","author":"CD Conrad","year":"1996","unstructured":"Conrad CD, Galea LAM, Kuroda Y, McEwen BS (1996) Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine treatment. Behav Neurosci 110:1321\u20131334. \n                    https:\/\/doi.org\/10.1037\/0735-7044.110.6.1321","journal-title":"Behav Neurosci"},{"key":"2032_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25392","author":"DG Coughlin","year":"2018","unstructured":"Coughlin DG, Xie SX, Liang M, Williams A, Peterson C, Weintraub D, McMillan CT, Wolk DA, Akhtar RS, Hurtig H, Coslett HB, Hamilton R, Siderowf A, Duda JE, Rascovsky K, Lee EB, Lee VMY, Grossman M, Trojanowski JQ, Irwin DJ (2018) Cognitive and pathological influences of tau pathology in lewy body disorders. Ann Neurol. \n                    https:\/\/doi.org\/10.1002\/ana.25392","journal-title":"Ann Neurol"},{"key":"2032_CR27","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jalz.2015.12.005","volume":"12","author":"MC de Wilde","year":"2016","unstructured":"de Wilde MC, Overk CR, Sijben JW, Masliah E (2016) Meta-analysis of synaptic pathology in Alzheimer\u2019s disease reveals selective molecular vesicular machinery vulnerability. Alzheimers Dement 12:633\u2013644. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2015.12.005","journal-title":"Alzheimers Dement"},{"key":"2032_CR28","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Elbaz A, Nichols E, Abd-Allah F, Abdelalim A, Adsuar JC et al (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939\u2013953. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"key":"2032_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-002-0563-3","volume":"104","author":"JE Duda","year":"2002","unstructured":"Duda JE, Giasson BI, Mabon ME, Miller DC, Golbe LI, Lee VM-Y et al (2002) Concurrence of \u03b1-synuclein and tau brain pathology in the Contursi kindred. Acta Neuropathol (Berl) 104:7\u201311. \n                    https:\/\/doi.org\/10.1007\/s00401-002-0563-3","journal-title":"Acta Neuropathol (Berl)"},{"key":"2032_CR30","doi-asserted-by":"publisher","first-page":"E912","DOI":"10.1073\/pnas.1512876113","volume":"113","author":"M-B Fares","year":"2016","unstructured":"Fares M-B, Maco B, Oueslati A, Rockenstein E, Ninkina N, Buchman VL et al (2016) Induction of de novo \u03b1-synuclein fibrillization in a neuronal model for Parkinson\u2019s disease. Proc Natl Acad Sci 113:E912\u2013E921. \n                    https:\/\/doi.org\/10.1073\/pnas.1512876113","journal-title":"Proc Natl Acad Sci"},{"key":"2032_CR31","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/nn.4648","volume":"20","author":"DG Ferreira","year":"2017","unstructured":"Ferreira DG, Temido-Ferreira M, Miranda HV, Batalha VL, Coelho JE, Szeg\u00f6 \u00c9M et al (2017) \u03b1-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B. Nat Neurosci 20:1569\u20131579. \n                    https:\/\/doi.org\/10.1038\/nn.4648","journal-title":"Nat Neurosci"},{"key":"2032_CR32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS et al (2002) \u03b1-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160\u2013164. \n                    https:\/\/doi.org\/10.1038\/ncb748","journal-title":"Nat Cell Biol"},{"key":"2032_CR33","first-page":"reviews3002.1","volume":"3","author":"JM George","year":"2002","unstructured":"George JM (2002) The synucleins. Genome Biol 3:reviews3002.1\u2013reviews3002.6","journal-title":"Genome Biol"},{"key":"2032_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0245-9","author":"JE Gerson","year":"2018","unstructured":"Gerson JE, Farmer KM, Henson N, Castillo-Carranza DL, Carretero Murillo M, Sengupta U et al (2018) Tau oligomers mediate \u03b1-synuclein toxicity and can be targeted by immunotherapy. Mol Neurodegener. \n                    https:\/\/doi.org\/10.1186\/s13024-018-0245-9","journal-title":"Mol Neurodegener"},{"key":"2032_CR35","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM-Y (2002) Neuronal \u03b1-synucleinopathy with severe movement disorder in mice expressing A53T human \u03b1-synuclein. Neuron 34:521\u2013533. \n                    https:\/\/doi.org\/10.1016\/S0896-6273(02)00682-7","journal-title":"Neuron"},{"key":"2032_CR36","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1126\/science.1082324","volume":"300","author":"BI Giasson","year":"2003","unstructured":"Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT et al (2003) Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300:636\u2013640. \n                    https:\/\/doi.org\/10.1126\/science.1082324","journal-title":"Science"},{"key":"2032_CR37","doi-asserted-by":"publisher","first-page":"6367","DOI":"10.1523\/JNEUROSCI.0395-10.2010","volume":"30","author":"DA Gimbel","year":"2010","unstructured":"Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Laur\u00e9n J, Gimbel ZA et al (2010) Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 30:6367\u20136374. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0395-10.2010","journal-title":"J Neurosci"},{"key":"2032_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1044-7431(03)00198-2","volume":"24","author":"S Gispert","year":"2003","unstructured":"Gispert S, Turco DD, Garrett L, Chen A, Bernard DJ, Hamm-Clement J et al (2003) Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation. Mol Cell Neurosci 24:419\u2013429. \n                    https:\/\/doi.org\/10.1016\/S1044-7431(03)00198-2","journal-title":"Mol Cell Neurosci"},{"key":"2032_CR39","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ana.410270309","volume":"27","author":"LI Golbe","year":"1990","unstructured":"Golbe LI, Iorio GD, Bonavita V, Miller DC, Duvoisin RC (1990) A large kindred with autosomal dominant Parkinson\u2019s disease. Ann Neurol 27:276\u2013282. \n                    https:\/\/doi.org\/10.1002\/ana.410270309","journal-title":"Ann Neurol"},{"key":"2032_CR40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/ana.21192","volume":"62","author":"A Goris","year":"2007","unstructured":"Goris A, Williams-Gray CH, Clark GR, Foltynie T, Lewis SJG, Brown J et al (2007) Tau and \u03b1-synuclein in susceptibility to, and dementia in, Parkinson\u2019s disease. Ann Neurol 62:145\u2013153. \n                    https:\/\/doi.org\/10.1002\/ana.21192","journal-title":"Ann Neurol"},{"key":"2032_CR41","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/jnr.22331","volume":"88","author":"DR Graham","year":"2010","unstructured":"Graham DR, Sidhu A (2010) Mice expressing the A53T mutant form of human alpha-synuclein exhibit hyperactivity and reduced anxiety-like behavior. J Neurosci Res 88:1777\u20131783. \n                    https:\/\/doi.org\/10.1002\/jnr.22331","journal-title":"J Neurosci Res"},{"key":"2032_CR42","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/brain\/awu193","volume":"137","author":"H Hall","year":"2014","unstructured":"Hall H, Reyes S, Landeck N, Bye C, Leanza G, Double K et al (2014) Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson\u2019s disease. Brain 137:2493\u20132508. \n                    https:\/\/doi.org\/10.1093\/brain\/awu193","journal-title":"Brain"},{"key":"2032_CR43","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s004010100390","volume":"102","author":"AJ Harding","year":"2001","unstructured":"Harding AJ, Halliday GM (2001) Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol (Berl) 102:355\u2013363. \n                    https:\/\/doi.org\/10.1007\/s004010100390","journal-title":"Acta Neuropathol (Berl)"},{"key":"2032_CR44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0896-6273(01)00462-7","volume":"32","author":"M Hashimoto","year":"2001","unstructured":"Hashimoto M, Rockenstein E, Mante M, Mallory M, Masliah E (2001) \u03b2-Synuclein inhibits \u03b1-synuclein aggregation: a possible role as an anti-Parkinsonian factor. Neuron 32:213\u2013223. \n                    https:\/\/doi.org\/10.1016\/S0896-6273(01)00462-7","journal-title":"Neuron"},{"key":"2032_CR45","first-page":"303","volume-title":"Behavioral neurobiology of Huntington\u2019s disease and Parkinson\u2019s disease","author":"A Hatami","year":"2015","unstructured":"Hatami A, Chesselet M-F (2015) Transgenic rodent models to study alpha-Synuclein pathogenesis, with a focus on cognitive deficits. In: Nguyen HHP, Cenci MA (eds) Behavioral neurobiology of Huntington\u2019s disease and Parkinson\u2019s disease. Springer, Berlin, pp 303\u2013330"},{"key":"2032_CR46","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WGJ, Adena MA, Halliday GM, Morris JGL (2008) The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov Disord 23:837\u2013844. \n                    https:\/\/doi.org\/10.1002\/mds.21956","journal-title":"Mov Disord"},{"key":"2032_CR47","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","volume":"68","author":"BR Hoover","year":"2010","unstructured":"Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK et al (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68:1067\u20131081. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2010.11.030","journal-title":"Neuron"},{"key":"2032_CR48","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00401-012-1013-5","volume":"124","author":"H Houlden","year":"2012","unstructured":"Houlden H, Singleton AB (2012) The genetics and neuropathology of Parkinson\u2019s disease. Acta Neuropathol (Berl) 124:325\u2013338. \n                    https:\/\/doi.org\/10.1007\/s00401-012-1013-5","journal-title":"Acta Neuropathol (Berl)"},{"key":"2032_CR49","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.neuron.2006.10.035","volume":"52","author":"H Hsieh","year":"2006","unstructured":"Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S et al (2006) AMPAR removal underlies A\u03b2-induced synaptic depression and dendritic spine loss. Neuron 52:831\u2013843. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2006.10.035","journal-title":"Neuron"},{"key":"2032_CR50","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ana.23659","volume":"72","author":"DJ Irwin","year":"2012","unstructured":"Irwin DJ, White MT, Toledo JB, Xie SX, Robinson JL, Van Deerlin V et al (2012) Neuropathologic substrates of Parkinson\u2019s disease dementia. Ann Neurol 72:587\u2013598. \n                    https:\/\/doi.org\/10.1002\/ana.23659","journal-title":"Ann Neurol"},{"key":"2032_CR51","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn3549","volume":"14","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Lee VM-Y, Trojanowski JQ (2013) Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies. Nat Rev Neurosci 14:626\u2013636. \n                    https:\/\/doi.org\/10.1038\/nrn3549","journal-title":"Nat Rev Neurosci"},{"key":"2032_CR52","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J et al (2010) Dendritic function of tau mediates amyloid-\u03b2 toxicity in Alzheimer\u2019s disease mouse models. Cell 142:387\u2013397. \n                    https:\/\/doi.org\/10.1016\/j.cell.2010.06.036","journal-title":"Cell"},{"key":"2032_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1016-8","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA, Korczyn AD (2018) Are dementia with Lewy bodies and Parkinson\u2019s disease dementia the same disease? BMC Med. \n                    https:\/\/doi.org\/10.1186\/s12916-018-1016-8","journal-title":"BMC Med"},{"key":"2032_CR54","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.parkreldis.2008.05.007","volume":"15","author":"ME Kalaitzakis","year":"2009","unstructured":"Kalaitzakis ME, Christian LM, Moran LB, Graeber MB, Pearce RKB, Gentleman SM (2009) Dementia and visual hallucinations associated with limbic pathology in Parkinson\u2019s disease. Park Relat Disord 15:196\u2013204. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2008.05.007","journal-title":"Park Relat Disord"},{"key":"2032_CR55","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1212\/WNL.0000000000003371","volume":"87","author":"K Kantarci","year":"2016","unstructured":"Kantarci K, Lesnick T, Ferman TJ, Przybelski SA, Boeve BF, Smith GE et al (2016) Hippocampal volumes predict risk of dementia with Lewy bodies in mild cognitive impairment. Neurology 87:2317\u20132323. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000003371","journal-title":"Neurology"},{"key":"2032_CR56","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00401-018-1886-z","volume":"136","author":"SS Khan","year":"2018","unstructured":"Khan SS, LaCroix M, Boyle G, Sherman MA, Brown JL, Amar F et al (2018) Bidirectional modulation of Alzheimer phenotype by alpha-synuclein in mice and primary neurons. Acta Neuropathol (Berl) 136:589\u2013605. \n                    https:\/\/doi.org\/10.1007\/s00401-018-1886-z","journal-title":"Acta Neuropathol (Berl)"},{"key":"2032_CR57","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrn.2017.75","volume":"18","author":"JB Koprich","year":"2017","unstructured":"Koprich JB, Kalia LV, Brotchie JM (2017) Animal models of \u03b1-synucleinopathy for Parkinson disease drug development. Nat Rev Neurosci 18:515\u2013529. \n                    https:\/\/doi.org\/10.1038\/nrn.2017.75","journal-title":"Nat Rev Neurosci"},{"key":"2032_CR58","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/brain\/awy318","volume":"142","author":"P La Vitola","year":"2019","unstructured":"La Vitola P, Beeg M, Balducci C, Santamaria G, Restelli E, Colombo L et al (2019) Cellular prion protein neither binds to alpha-synuclein oligomers nor mediates their detrimental effects. Brain 142:249\u2013254. \n                    https:\/\/doi.org\/10.1093\/brain\/awy318","journal-title":"Brain"},{"key":"2032_CR59","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1471-4159.2011.07478.x","volume":"120","author":"ME Larson","year":"2012","unstructured":"Larson ME, Lesn\u00e9 SE (2012) Soluble A\u03b2 oligomer production and toxicity. J Neurochem 120:125\u2013139. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07478.x","journal-title":"J Neurochem"},{"key":"2032_CR60","doi-asserted-by":"publisher","first-page":"16857","DOI":"10.1523\/JNEUROSCI.1858-12.2012","volume":"32","author":"ME Larson","year":"2012","unstructured":"Larson ME, Sherman MA, Amar F, Nuvolone M, Schneider JA, Bennett DA et al (2012) The complex PrPc\u2013Fyn couples human oligomeric A\u03b2 with pathological tau changes in Alzheimer\u2019s disease. J Neurosci 32:16857\u201316871. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1858-12.2012","journal-title":"J Neurosci"},{"key":"2032_CR61","doi-asserted-by":"publisher","first-page":"E4648","DOI":"10.1073\/pnas.1704698114","volume":"114","author":"ME Larson","year":"2017","unstructured":"Larson ME, Greimel SJ, Amar F, LaCroix M, Boyle G, Sherman MA et al (2017) Selective lowering of synapsins induced by oligomeric \u03b1-synuclein exacerbates memory deficits. Proc Natl Acad Sci 114:E4648\u2013E4657. \n                    https:\/\/doi.org\/10.1073\/pnas.1704698114","journal-title":"Proc Natl Acad Sci"},{"key":"2032_CR62","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1096\/fj.11-199851","volume":"26","author":"CA Lasagna-Reeves","year":"2012","unstructured":"Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Sarmiento J, Troncoso J, Jackson GR et al (2012) Identification of oligomers at early stages of tau aggregation in Alzheimer\u2019s disease. FASEB J 26:1946\u20131959. \n                    https:\/\/doi.org\/10.1096\/fj.11-199851","journal-title":"FASEB J"},{"key":"2032_CR63","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nature07761","volume":"457","author":"J Laur\u00e9n","year":"2009","unstructured":"Laur\u00e9n J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-\u03b2 oligomers. Nature 457:1128\u20131132. \n                    https:\/\/doi.org\/10.1038\/nature07761","journal-title":"Nature"},{"key":"2032_CR64","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1101\/gr.8.9.871","volume":"8","author":"C Lavedan","year":"1998","unstructured":"Lavedan C (1998) The synuclein family. Genome Res 8:871\u2013880. \n                    https:\/\/doi.org\/10.1101\/gr.8.9.871","journal-title":"Genome Res"},{"key":"2032_CR65","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.1073\/pnas.132197599","volume":"99","author":"MK Lee","year":"2002","unstructured":"Lee MK, Stirling W, Xu Y, Xu X, Qui D, Mandir AS et al (2002) Human \u03b1-synuclein-harboring familial Parkinson\u2019s disease-linked Ala-53-\u2009>\u2009Thr mutation causes neurodegenerative disease with \u03b1-synuclein aggregation in transgenic mice. Proc Natl Acad Sci 99:8968\u20138973. \n                    https:\/\/doi.org\/10.1073\/pnas.132197599","journal-title":"Proc Natl Acad Sci"},{"key":"2032_CR66","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1073\/pnas.0406976102","volume":"102","author":"W Li","year":"2005","unstructured":"Li W, West N, Colla E, Pletnikova O, Troncoso JC, Marsh L et al (2005) Aggregation promoting C-terminal truncation of \u03b1-synuclein is a normal cellular process and is enhanced by the familial Parkinson\u2019s disease-linked mutations. Proc Natl Acad Sci 102:2162\u20132167. \n                    https:\/\/doi.org\/10.1073\/pnas.0406976102","journal-title":"Proc Natl Acad Sci"},{"key":"2032_CR67","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.expneurol.2009.10.005","volume":"221","author":"Y Lim","year":"2010","unstructured":"Lim Y, Kehm VM, Li C, Trojanowski JQ, Lee VM-Y (2010) Forebrain overexpression of \u03b1-synuclein leads to early postnatal hippocampal neuron loss and synaptic disruption. Exp Neurol 221:86\u201397. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2009.10.005","journal-title":"Exp Neurol"},{"key":"2032_CR68","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1523\/JNEUROSCI.0618-11.2011","volume":"31","author":"Y Lim","year":"2011","unstructured":"Lim Y, Kehm VM, Lee EB, Soper JH, Li C, Trojanowski JQ et al (2011) \u03b1-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies. J Neurosci 31:10076\u201310087. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0618-11.2011","journal-title":"J Neurosci"},{"key":"2032_CR69","doi-asserted-by":"publisher","first-page":"12924","DOI":"10.1074\/jbc.M306390200","volume":"279","author":"E Lindersson","year":"2004","unstructured":"Lindersson E, Beedholm R, H\u00f8jrup P, Moos T, Gai W, Hendil KB et al (2004) Proteasomal inhibition by \u03b1-synuclein filaments and oligomers. J Biol Chem 279:12924\u201312934. \n                    https:\/\/doi.org\/10.1074\/jbc.M306390200","journal-title":"J Biol Chem"},{"key":"2032_CR70","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/j.1460-9568.2012.08012.x","volume":"35","author":"I Magen","year":"2012","unstructured":"Magen I, Fleming SM, Zhu C, Garcia EC, Cardiff KM, Dinh D et al (2012) Cognitive deficits in a mouse model of pre-manifest Parkinson\u2019s disease. Eur J Neurosci 35:870\u2013882. \n                    https:\/\/doi.org\/10.1111\/j.1460-9568.2012.08012.x","journal-title":"Eur J Neurosci"},{"key":"2032_CR71","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev.neuro.25.112701.142758","volume":"25","author":"R Malinow","year":"2002","unstructured":"Malinow R, Malenka RC (2002) AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 25:103\u2013126. \n                    https:\/\/doi.org\/10.1146\/annurev.neuro.25.112701.142758","journal-title":"Annu Rev Neurosci"},{"key":"2032_CR72","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0959-4388(00)00099-4","volume":"10","author":"R Malinow","year":"2000","unstructured":"Malinow R, Mainen ZF, Hayashi Y (2000) LTP mechanisms: from silence to four-lane traffic. Curr Opin Neurobiol 10:352\u2013357. \n                    https:\/\/doi.org\/10.1016\/S0959-4388(00)00099-4","journal-title":"Curr Opin Neurobiol"},{"key":"2032_CR73","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00401-008-0372-4","volume":"116","author":"K Markopoulou","year":"2008","unstructured":"Markopoulou K, Dickson D, McComb R, Wszolek Z, Katechalidou L, Avery L et al (2008) Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson\u2019s disease. Acta Neuropathol (Berl) 116:25\u201335. \n                    https:\/\/doi.org\/10.1007\/s00401-008-0372-4","journal-title":"Acta Neuropathol (Berl)"},{"key":"2032_CR74","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0169-328X(91)90043-W","volume":"11","author":"L Maroteaux","year":"1991","unstructured":"Maroteaux L, Scheller RH (1991) The rat brain synucleins; family of proteins transiently associated with neuronal membrane. Mol Brain Res 11:335\u2013343. \n                    https:\/\/doi.org\/10.1016\/0169-328X(91)90043-W","journal-title":"Mol Brain Res"},{"key":"2032_CR75","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuron.2018.02.029","volume":"98","author":"M Martinez-Losa","year":"2018","unstructured":"Martinez-Losa M, Tracy TE, Ma K, Verret L, Clemente-Perez A, Khan AS et al (2018) Nav1.1-overexpressing interneuron transplants restore brain rhythms and cognition in a mouse model of Alzheimer\u2019s disease. Neuron 98:75\u201389.e5. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2018.02.029","journal-title":"Neuron"},{"key":"2032_CR76","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/37605","volume":"390","author":"MG McKernan","year":"1997","unstructured":"McKernan MG, Shinnick-Gallagher P (1997) Fear conditioning induces a lasting potentiation of synaptic currents in vitro. Nature 390:607\u2013611. \n                    https:\/\/doi.org\/10.1038\/37605","journal-title":"Nature"},{"key":"2032_CR77","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/ejn.12507","volume":"39","author":"EC Miller","year":"2014","unstructured":"Miller EC, Teravskis PJ, Dummer BW, Zhao X, Huganir RL, Liao D (2014) Tau phosphorylation and tau mislocalization mediate soluble A\u03b2 oligomer-induced AMPA glutamate receptor signaling deficits. Eur J Neurosci 39:1214\u20131224. \n                    https:\/\/doi.org\/10.1111\/ejn.12507","journal-title":"Eur J Neurosci"},{"key":"2032_CR78","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1523\/JNEUROSCI.5215-08.2009","volume":"29","author":"R Minkeviciene","year":"2009","unstructured":"Minkeviciene R, Rheims S, Dobszay MB, Zilberter M, Hartikainen J, Fulop L et al (2009) Amyloid \u03b2-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci 29:3453\u20133462. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.5215-08.2009","journal-title":"J Neurosci"},{"key":"2032_CR79","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/acn3.257","volume":"2","author":"M Morris","year":"2015","unstructured":"Morris M, Sanchez PE, Verret L, Beagle AJ, Guo W, Dubal D et al (2015) Network dysfunction in \u03b1-synuclein transgenic mice and human Lewy body dementia. Ann Clin Transl Neurol 2:1012\u20131028. \n                    https:\/\/doi.org\/10.1002\/acn3.257","journal-title":"Ann Clin Transl Neurol"},{"key":"2032_CR80","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.nbd.2006.10.018","volume":"25","author":"AJ Myers","year":"2007","unstructured":"Myers AJ, Pittman AM, Zhao AS, Rohrer K, Kaleem M, Marlowe L et al (2007) The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol Dis 25:561\u2013570. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2006.10.018","journal-title":"Neurobiol Dis"},{"key":"2032_CR81","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","volume":"65","author":"VM Nemani","year":"2010","unstructured":"Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, Lee MK et al (2010) Increased expression of \u03b1-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65:66\u201379. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2009.12.023","journal-title":"Neuron"},{"key":"2032_CR82","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nm.2165","volume":"16","author":"JA Obeso","year":"2010","unstructured":"Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M et al (2010) Missing pieces in the Parkinson\u2019s disease puzzle. Nat Med 16:653\u2013661. \n                    https:\/\/doi.org\/10.1038\/nm.2165","journal-title":"Nat Med"},{"key":"2032_CR83","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-018-0874-y","author":"T Orme","year":"2018","unstructured":"Orme T, Guerreiro R, Bras J (2018) The genetics of dementia with Lewy bodies: current understanding and future directions. Curr Neurol Neurosci Rep. \n                    https:\/\/doi.org\/10.1007\/s11910-018-0874-y","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2032_CR84","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/brain\/awn349","volume":"132","author":"KE Paleologou","year":"2009","unstructured":"Paleologou KE, Kragh CL, Mann DMA, Salem SA, Al-Shami R, Allsop D et al (2009) Detection of elevated levels of soluble \u03b1-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies. Brain 132:1093\u20131101. \n                    https:\/\/doi.org\/10.1093\/brain\/awn349","journal-title":"Brain"},{"key":"2032_CR85","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12017-009-8097-7","volume":"12","author":"JJ Palop","year":"2010","unstructured":"Palop JJ, Mucke L (2010) Synaptic depression and aberrant excitatory network activity in Alzheimer\u2019s disease: two faces of the same coin? NeuroMol Med 12:48\u201355. \n                    https:\/\/doi.org\/10.1007\/s12017-009-8097-7","journal-title":"NeuroMol Med"},{"key":"2032_CR86","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrn.2016.141","volume":"17","author":"JJ Palop","year":"2016","unstructured":"Palop JJ, Mucke L (2016) Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci 17:777\u2013792. \n                    https:\/\/doi.org\/10.1038\/nrn.2016.141","journal-title":"Nat Rev Neurosci"},{"key":"2032_CR87","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nature05289","volume":"443","author":"JJ Palop","year":"2006","unstructured":"Palop JJ, Chin J, Mucke L (2006) A network dysfunction perspective on neurodegenerative diseases. Nature 443:768\u2013773. \n                    https:\/\/doi.org\/10.1038\/nature05289","journal-title":"Nature"},{"key":"2032_CR88","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","volume":"55","author":"JJ Palop","year":"2007","unstructured":"Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N et al (2007) Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s disease. Neuron 55:697\u2013711. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2007.07.025","journal-title":"Neuron"},{"key":"2032_CR89","first-page":"245","volume-title":"Alzheimer\u2019s disease and frontotemporal dementia: methods and protocols","author":"JJ Palop","year":"2011","unstructured":"Palop JJ, Mucke L, Roberson ED (2011) Quantifying biomarkers of cognitive dysfunction and neuronal network hyperexcitability in mouse models of Alzheimer\u2019s disease: depletion of calcium-dependent proteins and inhibitory hippocampal remodeling. In: Roberson ED (ed) Alzheimer\u2019s disease and frontotemporal dementia: methods and protocols. Humana Press, Totowa, pp 245\u2013262"},{"key":"2032_CR90","doi-asserted-by":"publisher","first-page":"e70274","DOI":"10.1371\/journal.pone.0070274","volume":"8","author":"KL Paumier","year":"2013","unstructured":"Paumier KL, Sukoff Rizzo SJ, Berger Z, Chen Y, Gonzales C, Kaftan E et al (2013) Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson\u2019s disease. PLoS One 8:e70274. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0070274","journal-title":"PLoS One"},{"key":"2032_CR91","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1037\/0735-7044.106.2.274","volume":"106","author":"RG Phillips","year":"1992","unstructured":"Phillips RG, LeDoux JE (1992) Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106:274\u2013285. \n                    https:\/\/doi.org\/10.1037\/0735-7044.106.2.274","journal-title":"Behav Neurosci"},{"key":"2032_CR92","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J et al (2017) Parkinson disease. Nat Rev Dis Primer 3:17013. \n                    https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primer"},{"key":"2032_CR93","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A et al (1997) Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047. \n                    https:\/\/doi.org\/10.1126\/science.276.5321.2045","journal-title":"Science"},{"key":"2032_CR94","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T et al (2007) Reducing endogenous tau ameliorates amyloid \u03b2-induced deficits in an Alzheimer\u2019s disease mouse model. Science 316:750\u2013754. \n                    https:\/\/doi.org\/10.1126\/science.1141736","journal-title":"Science"},{"key":"2032_CR95","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1523\/JNEUROSCI.4152-10.2011","volume":"31","author":"ED Roberson","year":"2011","unstructured":"Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, Yan F et al (2011) Amyloid-\u03b2\/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer\u2019s disease. J Neurosci 31:700\u2013711. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.4152-10.2011","journal-title":"J Neurosci"},{"key":"2032_CR96","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1074\/jbc.M115.705095","volume":"291","author":"F Samuel","year":"2016","unstructured":"Samuel F, Flavin WP, Iqbal S, Pacelli C, Sri Renganathan SD, Trudeau L-E et al (2016) Effects of Serine 129 phosphorylation on \u03b1-synuclein aggregation, membrane association, and internalization. J Biol Chem 291:4374\u20134385. \n                    https:\/\/doi.org\/10.1074\/jbc.M115.705095","journal-title":"J Biol Chem"},{"key":"2032_CR97","doi-asserted-by":"publisher","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","volume":"109","author":"PE Sanchez","year":"2012","unstructured":"Sanchez PE, Zhu L, Verret L, Vossel KA, Orr AG, Cirrito JR et al (2012) Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model. Proc Natl Acad Sci 109:E2895\u2013E2903. \n                    https:\/\/doi.org\/10.1073\/pnas.1121081109","journal-title":"Proc Natl Acad Sci"},{"key":"2032_CR98","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/nn.2213","volume":"11","author":"RO Sanchez-Mejia","year":"2008","unstructured":"Sanchez-Mejia RO, Newman JW, Toh S, Yu G-Q, Zhou Y, Halabisky B et al (2008) Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer\u2019s disease. Nat Neurosci 11:1311\u20131318. \n                    https:\/\/doi.org\/10.1038\/nn.2213","journal-title":"Nat Neurosci"},{"key":"2032_CR99","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","volume":"27","author":"SW Scheff","year":"2006","unstructured":"Scheff SW, Price DA, Schmitt FA, Mufson EJ (2006) Hippocampal synaptic loss in early Alzheimer\u2019s disease and mild cognitive impairment. Neurobiol Aging 27:1372\u20131384. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.09.012","journal-title":"Neurobiol Aging"},{"key":"2032_CR100","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ (2002) Alzheimer\u2019s disease is a synaptic failure. Science 298:789\u2013791. \n                    https:\/\/doi.org\/10.1126\/science.1074069","journal-title":"Science"},{"key":"2032_CR101","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.biopsych.2014.12.019","volume":"78","author":"U Sengupta","year":"2015","unstructured":"Sengupta U, Guerrero-Mu\u00f1oz MJ, Castillo-Carranza DL, Lasagna-Reeves CA, Gerson JE, Paulucci-Holthauzen AA et al (2015) Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies. Biol Psychiatry 78:672\u2013683. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2014.12.019","journal-title":"Biol Psychiatry"},{"key":"2032_CR102","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","volume":"27","author":"GM Shankar","year":"2007","unstructured":"Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007) Natural oligomers of the alzheimer amyloid-\u03b2 protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27:2866\u20132875. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.4970-06.2007","journal-title":"J Neurosci"},{"key":"2032_CR103","doi-asserted-by":"publisher","first-page":"9647","DOI":"10.1523\/JNEUROSCI.1899-16.2016","volume":"36","author":"MA Sherman","year":"2016","unstructured":"Sherman MA, LaCroix M, Amar F, Larson ME, Forster C, Aguzzi A et al (2016) Soluble conformers of A\u03b2 and tau alter selective proteins governing axonal transport. J Neurosci 36:9647\u20139658. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1899-16.2016","journal-title":"J Neurosci"},{"key":"2032_CR104","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M (1997) \u03b1-Synuclein in Lewy bodies. Nature 388:839\u2013840. \n                    https:\/\/doi.org\/10.1038\/42166","journal-title":"Nature"},{"key":"2032_CR105","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","volume":"251","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Anthony Crowther R, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous \u03b1-synuclein inclusions link multiple system atrophy with Parkinson\u2019s disease and dementia with Lewy bodies. Neurosci Lett 251:205\u2013208. \n                    https:\/\/doi.org\/10.1016\/S0304-3940(98)00504-7","journal-title":"Neurosci Lett"},{"key":"2032_CR106","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/ana.67","volume":"49","author":"PJ Spira","year":"2001","unstructured":"Spira PJ, Sharpe DM, Halliday G, Cavanagh J, Nicholson GA (2001) Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr \u03b1-synuclein mutation. Ann Neurol 49:313\u2013319. \n                    https:\/\/doi.org\/10.1002\/ana.67","journal-title":"Ann Neurol"},{"key":"2032_CR107","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.stem.2009.10.003","volume":"5","author":"B Sun","year":"2009","unstructured":"Sun B, Halabisky B, Zhou Y, Palop JJ, Yu G, Mucke L et al (2009) Imbalance between GABAergic and glutamatergic transmission impairs adult neurogenesis in an animal model of Alzheimer\u2019s disease. Cell Stem Cell 5:624\u2013633. \n                    https:\/\/doi.org\/10.1016\/j.stem.2009.10.003","journal-title":"Cell Stem Cell"},{"key":"2032_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2007.390","author":"B Sunyer","year":"2007","unstructured":"Sunyer B, Patil S, H\u00f6ger H, Lubec G (2007) Barnes maze, a useful task to assess spatial reference memory in the mice. Protoc Exch. \n                    https:\/\/doi.org\/10.1038\/nprot.2007.390","journal-title":"Protoc Exch"},{"key":"2032_CR109","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bbr.2008.12.034","volume":"200","author":"G Taglialatela","year":"2009","unstructured":"Taglialatela G, Hogan D, Zhang W-R, Dineley KT (2009) Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition. Behav Brain Res 200:95\u201399. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2008.12.034","journal-title":"Behav Brain Res"},{"key":"2032_CR110","doi-asserted-by":"publisher","first-page":"9754","DOI":"10.1523\/JNEUROSCI.0344-18.2018","volume":"38","author":"PJ Teravskis","year":"2018","unstructured":"Teravskis PJ, Covelo A, Miller EC, Singh B, Martell-Mart\u00ednez HA, Benneyworth MA et al (2018) A53T mutant alpha-synuclein induces tau-dependent postsynaptic impairment independently of neurodegenerative changes. J Neurosci 38:9754\u20139767. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0344-18.2018","journal-title":"J Neurosci"},{"key":"2032_CR111","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R et al (1991) Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572\u2013580. \n                    https:\/\/doi.org\/10.1002\/ana.410300410","journal-title":"Ann Neurol"},{"key":"2032_CR112","doi-asserted-by":"publisher","first-page":"e16706","DOI":"10.1371\/journal.pone.0016706","volume":"6","author":"B Thomas","year":"2011","unstructured":"Thomas B, Mandir AS, West N, Liu Y, Andrabi SA, Stirling W et al (2011) Resistance to MPTP-neurotoxicity in \u03b1-synuclein knockout mice is complemented by human \u03b1-synuclein and associated with increased \u03b2-synuclein and Akt activation. PLoS One 6:e16706. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0016706","journal-title":"PLoS One"},{"key":"2032_CR113","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/82868","volume":"4","author":"KL Tucker","year":"2001","unstructured":"Tucker KL, Meyer M, Barde Y-A (2001) Neurotrophins are required for nerve growth during development. Nat Neurosci 4:29\u201337. \n                    https:\/\/doi.org\/10.1038\/82868","journal-title":"Nat Neurosci"},{"key":"2032_CR114","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/nn.3178","volume":"15","author":"JW Um","year":"2012","unstructured":"Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A et al (2012) Alzheimer amyloid-\u03b2 oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci 15:1227\u20131235. \n                    https:\/\/doi.org\/10.1038\/nn.3178","journal-title":"Nat Neurosci"},{"key":"2032_CR115","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","volume":"79","author":"JW Um","year":"2013","unstructured":"Um JW, Kaufman AC, Kostylev M, Heiss JK, Stagi M, Takahashi H et al (2013) Metabotropic glutamate receptor 5 is a coreceptor for alzheimer A\u03b2 oligomer bound to cellular prion protein. Neuron 79:887\u2013902. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2013.06.036","journal-title":"Neuron"},{"key":"2032_CR116","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.nbd.2005.08.005","volume":"21","author":"EL Unger","year":"2006","unstructured":"Unger EL, Eve DJ, Perez XA, Reichenbach DK, Xu Y, Lee MK et al (2006) Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human \u03b1-synuclein in mice. Neurobiol Dis 21:431\u2013443. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2005.08.005","journal-title":"Neurobiol Dis"},{"key":"2032_CR117","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","volume":"149","author":"L Verret","year":"2012","unstructured":"Verret L, Mann EO, Hang GB, Barth AMI, Cobos I, Ho K et al (2012) Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 149:708\u2013721. \n                    https:\/\/doi.org\/10.1016\/j.cell.2012.02.046","journal-title":"Cell"},{"key":"2032_CR118","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1126\/science.1194653","volume":"330","author":"KA Vossel","year":"2010","unstructured":"Vossel KA, Zhang K, Brodbeck J, Daub AC, Sharma P, Finkbeiner S et al (2010) Tau reduction prevents A\u03b2-induced defects in axonal transport. Science 330:198. \n                    https:\/\/doi.org\/10.1126\/science.1194653","journal-title":"Science"},{"key":"2032_CR119","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1073\/pnas.98.4.1982","volume":"98","author":"X Zhuang","year":"2001","unstructured":"Zhuang X, Oosting RS, Jones SR, Gainetdinov RR, Miller GW, Caron MG et al (2001) Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc Natl Acad Sci 98:1982\u20131987. \n                    https:\/\/doi.org\/10.1073\/pnas.98.4.1982","journal-title":"Proc Natl Acad Sci"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-02032-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-019-02032-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-02032-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T23:35:16Z","timestamp":1591313716000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-019-02032-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["2032"],"URL":"https:\/\/doi.org\/10.1007\/s00401-019-02032-w","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,6]]},"assertion":[{"value":"12 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"SEL is a scientific consultant for Acelot, Inc. and has no actual or potential conflict of interest in relation to this study. All other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}